India has seen a troubling rise in mumps cases, prompting health professionals to call for the mumps vaccine's inclusion in the Universal Immunisation Programme. This discussion is critical for enhancing public health and preventing future outbreaks.

Mumps is a viral infection primarily affecting the salivary glands, causing serious complications, especially in adults. Currently, India's Universal Immunisation Programme does not cover mumps, despite available vaccines that can protect children.

In early 2025, pediatricians urged the government to add the mumps vaccine to the immunisation schedule due to ongoing outbreaks. Tamil Nadu's government echoed this plea, highlighting the importance of protecting all children from mumps.

Without mumps included in the immunisation schedule, only those who can afford private healthcare receive the vaccine. This leaves many children vulnerable, highlighting the need for equitable access to necessary vaccinations.

Recent reports show a worrying trend of mumps cases among children between 3 and 12 years. Cerious outbreaks, like the 2017 Kashmir case, underline the necessity for preventive vaccines to improve public health outcomes.

Incorporating the mumps vaccine into India's UIP could drastically reduce outbreaks, lower healthcare costs, and ensure all children access vital vaccinations, enhancing overall public health and community immunity.

Discussions on including the mumps vaccine reflect larger public health priorities in India. If implemented, it could set a strong precedent for addressing other vaccine-preventable diseases and improve health outcomes nationwide.